120 related articles for article (PubMed ID: 11875671)
21. Ifosfamide metabolite chloroacetaldehyde causes renal dysfunction in vivo.
Springate JE
J Appl Toxicol; 1997; 17(1):75-9. PubMed ID: 9048231
[TBL] [Abstract][Full Text] [Related]
22. The nephrotoxic Ifosfamide-metabolite chloroacetaldehyde interferes with renal extracellular matrix homeostasis.
Benesic A; Schwerdt G; Hennemeier I; Sauvant C; Mildenberger S; Gekle M
Cell Physiol Biochem; 2014; 33(4):1106-16. PubMed ID: 24732969
[TBL] [Abstract][Full Text] [Related]
23. Metabolism of ifosfamide to chloroacetaldehyde contributes to antitumor activity in vivo.
Börner K; Kisro J; Brüggemann SK; Hagenah W; Peters SO; Wagner T
Drug Metab Dispos; 2000 May; 28(5):573-6. PubMed ID: 10772637
[TBL] [Abstract][Full Text] [Related]
24. Ifosfamide-induced nephrotoxicity: mechanism and prevention.
Nissim I; Horyn O; Daikhin Y; Nissim I; Luhovyy B; Phillips PC; Yudkoff M
Cancer Res; 2006 Aug; 66(15):7824-31. PubMed ID: 16885387
[TBL] [Abstract][Full Text] [Related]
25. Comparative pharmacokinetics of ifosfamide, 4-hydroxyifosfamide, chloroacetaldehyde, and 2- and 3-dechloroethylifosfamide in patients on fractionated intravenous ifosfamide therapy.
Kurowski V; Wagner T
Cancer Chemother Pharmacol; 1993; 33(1):36-42. PubMed ID: 8269587
[TBL] [Abstract][Full Text] [Related]
26. Ifosfamide nephrotoxicity in children: a mechanistic base for pharmacological prevention.
Hanly L; Chen N; Rieder M; Koren G
Expert Opin Drug Saf; 2009 Mar; 8(2):155-68. PubMed ID: 19309244
[TBL] [Abstract][Full Text] [Related]
27. Ifosfamide metabolites CAA, 4-OH-Ifo and Ifo-mustard reduce apical phosphate transport by changing NaPi-IIa in OK cells.
Patzer L; Hernando N; Ziegler U; Beck-Schimmer B; Biber J; Murer H
Kidney Int; 2006 Nov; 70(10):1725-34. PubMed ID: 17003823
[TBL] [Abstract][Full Text] [Related]
28. Cadmium chloride inhibits lactate gluconeogenesis in isolated human renal proximal tubules: a cellular metabolomic approach with 13C-NMR.
Faiz H; Conjard-Duplany A; Boghossian M; Martin G; Baverel G; Ferrier B
Arch Toxicol; 2011 Sep; 85(9):1067-77. PubMed ID: 21153630
[TBL] [Abstract][Full Text] [Related]
29. The metabolic fate of lactate in renal cortical tubules.
Janssens P; Hems R; Ross B
Biochem J; 1980 Jul; 190(1):27-37. PubMed ID: 7447933
[TBL] [Abstract][Full Text] [Related]
30. Ifosfamide toxicity in cultured proximal renal tubule cells.
Springate J; Taub M
Pediatr Nephrol; 2007 Mar; 22(3):358-65. PubMed ID: 17072651
[TBL] [Abstract][Full Text] [Related]
31. Cadmium chloride inhibits lactate gluconeogenesis in mouse renal proximal tubules: An in vitro metabolomic approach with (13)C NMR.
Faiz H; Boghossian M; Martin G; Baverel G; Ferrier B; Conjard-Duplany A
Toxicol Lett; 2015 Nov; 238(3):45-52. PubMed ID: 26235813
[TBL] [Abstract][Full Text] [Related]
32. Amino-acid-dependent, differential effects of ethanol on glucose production in rabbit kidney-cortex tubules.
Derlacz RA; Jagielski AK; Kiersztan A; Winiarska K; Drozak J; Poplawski P; Wegrzynowicz M; Chodnicka K; Bryla J
Alcohol Alcohol; 2004; 39(2):93-100. PubMed ID: 14998823
[TBL] [Abstract][Full Text] [Related]
33. Inhibition and stimulation of long-chain fatty acid oxidation by chloroacetaldehyde and methylene blue in rats.
Visarius TM; Stucki JW; Lauterburg BH
J Pharmacol Exp Ther; 1999 May; 289(2):820-4. PubMed ID: 10215658
[TBL] [Abstract][Full Text] [Related]
34. Uranyl nitrate inhibits lactate gluconeogenesis in isolated human and mouse renal proximal tubules: a 13C-NMR study.
Renault S; Faiz H; Gadet R; Ferrier B; Martin G; Baverel G; Conjard-Duplany A
Toxicol Appl Pharmacol; 2010 Jan; 242(1):9-17. PubMed ID: 19747499
[TBL] [Abstract][Full Text] [Related]
35. 2-Chloroacetaldehyde-induced cerebral glutathione depletion and neurotoxicity.
Sood C; O'Brien PJ
Br J Cancer Suppl; 1996 Jul; 27():S287-93. PubMed ID: 8763899
[TBL] [Abstract][Full Text] [Related]
36. Characteristics of acetaldehyde metabolism in isolated dog, rat and guinea-pig kidney tubules.
Michoudet C; Baverel G
Biochem Pharmacol; 1987 Nov; 36(22):3987-91. PubMed ID: 3689431
[TBL] [Abstract][Full Text] [Related]
37. Mutagenicity of vinyl chloride and its reactive metabolites, chloroethylene oxide and chloroacetaldehyde, in a metabolically competent human B-lymphoblastoid line.
Chiang SY; Swenberg JA; Weisman WH; Skopek TR
Carcinogenesis; 1997 Jan; 18(1):31-6. PubMed ID: 9054586
[TBL] [Abstract][Full Text] [Related]
38. Effects of chloroacetaldehyde in 2-chloroethanol-induced cardiotoxicity.
Chen YT; Hsu CI; Hung DZ; Matsuura I; Liao JW
Food Chem Toxicol; 2011 May; 49(5):1063-7. PubMed ID: 21266185
[TBL] [Abstract][Full Text] [Related]
39. AlkB influences the chloroacetaldehyde-induced mutation spectra and toxicity in the pSP189 supF shuttle vector.
Kim MY; Zhou X; Delaney JC; Taghizadeh K; Dedon PC; Essigmann JM; Wogan GN
Chem Res Toxicol; 2007 Aug; 20(8):1075-83. PubMed ID: 17658757
[TBL] [Abstract][Full Text] [Related]
40. Investigation of ifosfamide nephrotoxicity induced in a liver-kidney co-culture biochip.
Choucha-Snouber L; Aninat C; Grsicom L; Madalinski G; Brochot C; Poleni PE; Razan F; Guillouzo CG; Legallais C; Corlu A; Leclerc E
Biotechnol Bioeng; 2013 Feb; 110(2):597-608. PubMed ID: 22887128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
